Mirapex (pramipexole) will be the first drug approved to treat restless legs syndrome
November 2006
Mirapex (pramipexole) will be the first drug approved to treat restless legs syndrome in Canada.
Restless legs syndrome affects about 5% to 15% of the population. Patients usually have tingling in their legs at rest, along with an irresistible urge to move the legs.
About 90% have problems getting to sleep and falling asleep.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive